11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 315 / 薬物数 : 232 - (DrugBank : 77) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 126

8 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04768465 (ClinicalTrials.gov)	January 1, 2021	21/2/2021	Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis	Effectiveness and Safety of Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis: A Real-world Study	Myasthenia Gravis	Drug: Pyridostigmine , Prednisone, Tacrolimus;Drug: Pyridostigmine , Tacrolimus	Da, Yuwei, M.D.	NULL	Recruiting	18 Years	N/A	All	160		China
2	NCT04182984 (ClinicalTrials.gov)	November 4, 2019	26/11/2019	TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study	TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study	Ocular Myasthenia Gravis	Drug: Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)	Tang-Du Hospital	NULL	Recruiting	18 Years	75 Years	All	200		China
3	JPRN-UMIN000015019	2014/09/02	02/09/2014	Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG		Myasthenia gravis	Tacrolimus and IVIG	Kansai medical university	NULL	Recruiting	Not applicable	Not applicable	Male and Female	20	Not applicable	Japan
4	JPRN-UMIN000007671	2012/04/01	09/04/2012	Randomized comparative study on efficacy and safety of reduced-dose steroid combined with tacrolimus vs conventional-dose steroid in late- or elderly-onset myasthenia gravis patients		Myasthenia gravis	Administration of prednisolone 35 mg/day with tacrolimus 3mg a day Administration of prednisolone 50 mg/day	Department of Neurology, Chiba University Graduate School of Medicine	NULL	Recruiting	50years-old	Not applicable	Male and Female	40	Not applicable	Japan
5	JPRN-UMIN000007679	2012/04/01	09/04/2012	Randomized comparative study on efficacy and safety of tacrolimus, prednisolone or placebo in ocular myasthenia gravis patients		Myasthenia gravis	Administration of tacrolimus 3 mg/day Administration of prednisolone 5 mg/day anticholinesterases	Department of Neurology, Chiba University Graduate School of Medicine	NULL	Recruiting	20years-old	Not applicable	Male and Female	60	Not selected	Japan
6	NCT01325571 (ClinicalTrials.gov)	March 2011	16/3/2011	A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis	A Randomized, Double-blinded, Placebo-controlled, and Multi-centered Clinical Trial Evaluating the Efficacy and Safety of Tacrolimus Capsule in Myasthenia Gravis That Was Insufficiently Treated by Glucocorticoid Therapy	Myasthenia Gravis	Drug: Tacrolimus capsule;Drug: Placebo	Astellas Pharma Inc	Astellas Pharma China, Inc.	Completed	18 Years	70 Years	Both	83	Phase 3	China
7	NCT00309088 (ClinicalTrials.gov)	April 2006	29/3/2006	FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients	FK506 Phase 3 Study: a Double Blind Placebo Controlled Study for Steroid Non-Resistant Myasthenia Gravis Patients	Myasthenia Gravis	Drug: tacrolimus;Drug: placebo	Astellas Pharma Inc	NULL	Completed	16 Years	64 Years	Both	80	Phase 3	Japan
8	NCT00309101 (ClinicalTrials.gov)	February 2006	29/3/2006	An Open Study for Steroid Resistant, Non-Thymectomized MG Patients	FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients	Myasthenia Gravis	Drug: tacrolimus	Astellas Pharma Inc	NULL	Completed	16 Years	64 Years	Both	11	Phase 3	Japan

先頭へ